YSB Inc. (HKG:9885)
Hong Kong · Delayed Price · Currency is HKD 3.485
-0.095 (-2.65%)
Sep 11, 2026, 4:08 PM HKT
YSB Inc. Revenue
YSB Inc. had revenue of 10.28B CNY in the half year ending June 30, 2026, with 16.67% growth. This brings the company's revenue in the last twelve months to 21.41B, up 13.09% year-over-year. In the year 2025, YSB Inc. had annual revenue of 20.97B with 17.13% growth.
Revenue (ttm)
21.41B CNY
Revenue Growth
+13.09%
P/S Ratio
0.10
Revenue / Employee
3.15M CNY
Employees
6,795
Market Cap
2.38B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.97B | 3.07B | 17.13% |
| Dec 31, 2024 | 17.90B | 931.33M | 5.49% |
| Dec 31, 2023 | 16.97B | 2.70B | 18.90% |
| Dec 31, 2022 | 14.27B | 4.18B | 41.43% |
| Dec 31, 2021 | 10.09B | 4.03B | 66.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 91.25B |
| Alibaba Health Information Technology | 38.94B |
| Fangzhou | 4.45B |
| Shanghai Pioneer Holding | 1.43B |
| Tycoon Group Holdings | 1.08B |
| Kingworld Medicines Group | 909.57M |
| Universal Health International Group Holding | 597.78M |
| New Ray Medicine International Holding | 199.09M |